Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction? | Zendy

Frederick A. Spencer | Zendy; Mauro Moscucci | Zendy; Christopher B. Granger | Zendy; Joel M. Gore | Zendy; Robert J. Goldberg | Zendy; Philippe Gabríel Steg | Zendy; Shaun G. Goodman | Zendy; Andrzej Budaj | Zendy; Gordon FitzGerald | Zendy; Keith A.A. Fox | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?

Author(s) -

Frederick A. Spencer,

Mauro Moscucci,

Christopher B. Granger,

Joel M. Gore,

Robert J. Goldberg,

Philippe Gabríel Steg,

Shaun G. Goodman,

Andrzej Budaj,

Gordon FitzGerald,

Keith A.A. Fox

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.694273

Subject(s) - medicine , myocardial infarction , hazard ratio , aspirin , confidence interval , randomized controlled trial , comorbidity , adverse effect , cardiology

Analyses from randomized controlled trials suggest that bleeding in patients with acute myocardial infarction is associated with poor outcomes. Because these data are not generalizable to all patients with acute myocardial infarction, we sought to better understand the scope of this problem in a "real-world" setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research